Acute risk factors in fatal opioid overdoses as a result of hypoxia and cardiotoxicity. A systematic review and critical appraisal by Baldacchino, Alexander Mario et al.
Review
Heroin Addict Relat Clin Probl 2016; 18(4): 33-42
33
Corresponding author: Professor Alex Baldacchino, Medical and Biological Sciences, North Haugh, University of St Andrews, St 
Andrews, Fife, U.K. 
E-mail: amb30@st-andrews.ac.uk
Acute risk factors in fatal opioid overdoses as a result of hypoxia and 
cardiotoxicity. A systematic review and critical appraisal
Alexander Baldacchino1,2, Serenella Tolomeo2, Faisel Khan3, Gerry Humphris1, 
and Giuseppe Carrà4
1 Medical and Biological Sciences, North Haugh, University of St Andrews, St Andrews, Fife, U.K.
2 Division of Neurosciences, Ninewells Hospital and Medical School, University of Dundee, Dundee, U.K. 
3 Division of Cardiovascular Medicine, Ninewells Hospital and Medical School University of Dundee, Dundee, U.K. 
4 Division of Psychiatry, Bloomsbury Campus, Charles Bell House, University College London (UCL), University of London, 
London, U.K. 
Summary
Background: The rates of fatal opioid overdoses (FOO) have increased rapidly over the last 10 years. The actual phe-
nomenon occurs as a result of a toxic opioid effect on the cardiorespiratory system. Aims: The systematic review aimed 
to identify the acute risk factors in fatal opioid overdose (FOO) as a result of hypoxia and cardiotoxicity. Methods: A 
systematic review was undertaken. The selection of papers has utilised rigorous criteria of inclusion/exclusion, controlled 
for heterogeneity. Results: A total of thirteen articles met the inclusion criteria. Ten of the thirteen studies included were 
retrospective and the other three studies employed different designs namely longitudinal cohort, case control and case 
cohort. Factors that were modestly described with increased acute risk of FOO due to hypoxia and cardiotoxicity include 
multiple sedative use (opioids and alcohol), reduced tolerance and presence of an acute painful condition. Conclusion: 
This systematic review has highlighted the lack of information on acute risk factors of FOO due to hypoxia and cardiotox-
icity. Future studies need to explore possible mechanisms underlying cardiotoxicity such as reported changes in arterial 
stiffness in opioid dependent populations and the unexplored potential effects on endothelial function.
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1. Introduction
Rates of fatal opioid overdoses (FOO) have in-
creased rapidly over the last 30 years [25]. For ex-
ample, in 2010, the average EU mortality rate was 
estimated at 13 overdose deaths per million in pop-
ulation, with higher rates among younger cohorts. 
Among the adult population the estimated rate of 
FOO is 18.3 deaths per million. The use of opioids, 
in particular the use of heroin, accounts for 74% of 
overdose deaths in Europe [49].
Both acute and chronic risk factors [54, 38] 
identified in the literature were grouped into the fol-
lowing domains of (1) polydrug use and other drug 
taking behaviours, (2) comorbid health issues and 
(3) prescribing. Overall, those who overdose tend 
to be males with a long history of substance abuse, 
co-morbid depressive disorders [3] have a propensity 
to engage in polydrug use [9, 32], require assistance 
with injection, and have a history of being denied or 
non-complying to treatment [49,13,55,10]. In the UK 
and other European countries, most illicit substance-
related fatal overdoses involve opioids [16, 15, 14, 
21]. The concurrent use of heroin combined with al-
cohol and benzodiazepines poses a particular threat, 
as the presence of such central nervous system de-
pressants can cause a drug user’s normal heroin dos-
age to prove fatal [41]. An individual’s tolerance to 
a particular substance can also be reduced during a 
period of forced abstinence such as during incarcera-
tion [29] 
However, despite having gained knowledge of 
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these mainly chronic factors FOO continues to be a 
significant contributor to the mortality of dependent 
individuals [13]. 
The primary mechanism of death is opioid-
induced respiratory depression, although hypoxia-
induced cardiac arrest and arrhythmia may also oc-
cur [19, 24, 51]. In such cases of FOO, the victim’s 
breathing slows to the point where oxygen levels in 
the blood fall below the level needed to transfer oxy-
gen to the vital organs. As oxygen saturation (normal-
ly greater than 97 per cent) falls below 86 per cent, the 
brain struggles to function. Typically, the individual 
becomes unresponsive, blood pressure progressively 
decreases and the heart rate slows, ultimately leading 
to cardiac arrest. Death can occur within minutes of 
opioid ingestion but often, prior to death there is a 
longer period of unresponsiveness lasting up to sev-
eral hours. This period is sometimes associated with 
loud snoring, leading to the term ‘unrousable snorers’ 
[52].
There is a fundamental limitation to the inter-
pretations of acute factors. Methodologically the in-
formation collated is based on a flawed assumption 
that all FOO cases have had a: (1) comprehensive and 
timely police identification and (2) comprehensive 
toxicological analysis to all licit and illicit substanc-
es and (3) an objective contextualised and evidence 
based interpretation of the data obtained from both 
toxicology and post-mortem results [19]. This is com-
pounded by the fact that the definition of an FOO is 
not only complex, but with individual studies adopt-
ing specific definitions, which vary depending upon 
the focus of the study and also upon the competen-
cies of the individuals determining if such a case is an 
FOO or not [26]. Therefore such interpretations are 
currently due to the interpretation of the toxicology 
results rather than to a standardised, objective, repro-
ducible and valid operationalised process to identify-
ing FOO [23].
The aim of this systematic review was to focus 
on the acute risk factors contributing to fatal opioid 
overdose as a result of hypoxia and/or cardiotoxicity. 
2. Methods
Systematic reviews providing a logical, trans-
parent and reproducible synthesis of all current lit-
erature evidence, within specified criteria, seem an 
ideal framework to study healthcare issues [7] such 
as acute risk factors contributing to FOO as a result of 
hypoxia and/or cardiotoxicity. This systematic review 
was based upon the Meta-analysis of Observational 
Studies in Epidemiology (MOOSE) guidelines [43].
2.1. Search strategy
The following electronic databases were 
searched: PUBMED (1950 to 2013), PsycINFO 
(1940 to 2013), CINAHL (1940 to 2013). In order 
to select the maximum number of relevant references 
a search strategy consisting of the following terms 
were applied when available: Risk factors/hypoxia/ 
cardiotoxicity/sociocultural factors/psychosocial fac-
tors/risk assessment AND opioids/analgesics, nar-
cotics/opiate alkaloids/opium/morphine/methadone/
buprenorphine/heroin OR opioids/analgesics/nar-
cotics/opiate alkaloids/opium/morphine/methadone/
buprenorphine/heroin AND fatal outcome/mortality/
death/hypoxia/cardiotoxocity/poisoning/overdose/
fatal.
2.2. Included studies
Studies included in the review were required to 
deal with all of the following elements:
Opioids: The term encompasses opiates (natu-
rally obtained alkaloids from the resin of the opium 
poppy) as well as synthetic opioids [31]. Articles 
which examined a broader spectrum of drugs were in-
cluded provided results were available which referred 
to opioids specifically.
Fatal overdose: Opioid overdose deaths are 
those caused by acute respiratory depression as a di-
rect consequence of the drug administration (i.e. hy-
poxia) [51]. This review was interested in determining 
the risk factors for fatal overdoses as opposed to non-
fatal. Given this, articles which looked at overdoses in 
general were included only when results for fatal and 
non-fatal were provided independently. Those articles 
concerned with deaths related to the chronic effects of 
drug use, such as systemic diseases for example liver 
pathology or road traffic accidents, were not included 
in this review. Articles which looked at overall mor-
tality from drug use were included provided results 
were available which referred to opioid overdose spe-
cifically. 
Risk factors: For the purposes of this review 
these were defined as any characteristic, condition, 
or behaviour associated with an increased risk of hy-
poxia and/or cardiotoxicity resulting in FOO. Predis-
posing factors (genetic, attitudinal, personality, and 
environmental factors associated with health, or lack 
of it) in a person [31] were not included in this review. 
This review focused on deaths clearly attributed to an 
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episode of hypoxia and/or cardiotoxicity.
Age range: Drug metabolism is different in 
adults than in children [8], hence, it was prudent to 
consider risk factors for childhood and adult overdos-
es separately. Participants in studies met a minimum 
age requirement of 16 years in order to be included. 
Studies which provided a mean age of participant, but 
no age range, were therefore excluded.
Self-administered: The opioids were required 
to be self-administered for inclusion in the review. 
With the exclusion of reports referring to hospital ad-
ministered opioids, this review avoided the complex 
administrative errors within the healthcare system 
which unfortunately are known to cause opioid over-
doses [48].
Accidental: This study was concerned spe-
cifically with accidental (non-deliberate) overdose 
deaths and not suicides from opioid overdose. Risk 
factors for suicides are likely to be different from ac-
cidental overdose (e.g. may involve more psychiatric 
co-morbidities) [17].
Number of overdose deaths: It is difficult to as-
certain the relevance of any given finding from stud-
ies involving very few subjects and therefore only 
larger studies were included. The criteria of, at least 
10 opioid deaths, was applied to satisfy this specifica-
tion.
2.3. Study design, selection process and data extrac-
tion
All types of experimental designs were included 
in this systematic review [36]. Data were extracted by 
two reviewers using a ‘search diary’ created listing 
the names of the databases searched, the keywords 
used and the search results.
The initial selection process involved reading 
the titles of the search results and discarding those 
which were obviously irrelevant to this review. Those 
titles in which there was ambiguity regarding their rel-
evance were still included. This approach left less risk 
of excluding relevant articles at this early stage. Fol-
Figure 1. Identified studies
 
 
Figure1. I entified studies 
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lowing this, these abstracts and those found through 
snowballing techniques were reviewed and matched 
to the inclusion criteria. Those articles which met 
the criteria and those in which it was unclear were 
then read in full. Finally, only those in which the full 
article matched the inclusion criteria were included 
in the review. The acute risk factors identified from 
these papers were then arbitrarily recorded and listed 
into the following areas: (1) drug taking behaviours 
and purity, and (2) prescribing and treatment.
2.4. Data analysis
There was no attempt to undertake any meta-
analyses, exploring associations or correlations, and 
our approach was just systematically descriptive. 
3. Results
3.1. Included articles
A total of thirteen articles were found in which 
acute risk factors for FOO were quantified [5, 11, 10, 
18, 20, 22, 30, 33, 34, 35, 44, 46, 53, 4] (Figure 1).
The total number of potential FOO incidents in-
vestigated was 3803. The mean age of overdose vic-
tims was 33.1 years and about 80% were male. Ten 
of the thirteen included articles were retrospective 
studies in which post-mortem autopsy and toxicology 
examinations were performed. The remaining three 
studies employed different designs namely longitudi-
nal cohort, case control and case cohort. The oldest 
article included was dated 1991 (Table 1).
Table 1- General characteristics of selected studies
Study Mean Age (years)
Male 
(%) Ethnicity (%) Country
Type of 
opioid
Opioid de-
aths exami-
ned (N)
Study type
Green et al. 
(2011) n/a 70.5
Caucasian-93
Other-7 USA Opioid 1975
Retrospective 
cohort
Minett et al. 
(2010) 38.8 72 n/a USA Opiates 161
Retrospective 
cohort
Henderson et al. 
(1991) 32.5 78
Caucasian-50
Hispanic-29
Black-20
Asian-1
USA Fentanyl 112 Retrospective cohort
Darke et al. 
(1999) 29.2 87 n/a Australia Heroin 61
Retrospective 
cohort
Perret et al. 
(2000) n/a 85 n/a Switzerland
Methadone/
morphine 36
Retrospective 
cohort
Fugelstad et al. 
(2003) n/a 87 n/a Sweden Heroin 192
Retrospective 
cohort
Wolf et al. 
(2004) 38.6 78.4
Caucasian- 96
Black-4 USA Methadone 98
Retrospective 
cohort
Thiblin et al. 
(2004) n/a 85 n/a Sweden Heroin 192
Retrospective 
cohort
Ødegart et al. 
(2007) 32.9 65 n/a Norway Opioid 88
Longitudinal 
Cohort
Oliver et al. 
(2007) 32 94 Caucasian UK Opiates 15 Case-control
Bohnert et al. 
(2011) n/a 93
Black – 6.9
White- 83.6
Hispanic- 3.1
Other- 9.7
USA Opioid 750 Case Cohort
Darke et al. 
(1997) 28 70 n/a Australia Heroin 39
Retrospective 
cohort
Tagliaro et al. 
(1998) n/a 78.4 n/a Italy Heroin 37
Retrospective 
cohort
N= number; n/a= not available; opioids=any drug which produce their effects through activity at the mu, kappa and delta recep-
tors; opiates= opioids naturally obtained from the resin of the opium poppy; morphine= a specific alkaloid extracted from opium; 
heroin= a powder derived from morphine; methadone=a synthetic opioid C 21 H
27 NO used in heroin addiction treatment and analgesia; fentanyl= a synthetic opioid C22H28N2O used in analgesia (definitions 
from Merriam-Webster Medical Dictionary; available at http://www.merriam-webster.com/)
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with risk factors for opioids specifically. Eleven ar-
ticles looked at mortality, often drug related, but did 
not specify that the mortality was caused by an opioid 
overdose. Other reasons for exclusion were papers 
describing less than ten mortalities (N=3), not dis-
cussing mortality at all (N=3), not discussing relevant 
risk factors (N=6), including suicides (N=9) and/or 
3.2. Excluded studies
Fifty one from the 103 articles excluded after a 
full reading did not provide an age range and/or the 
age of subjects accepted was younger than 16 years. 
Fourteen articles were excluded because, although 
they discussed overdose mortalities, they did not deal 
Table 2: Presence of plasma levels in FOO cases
STUDY
Total 
Num-
ber (N)
Alcohol
% (n) Benzo
Antide-
pressants Cocaine
Ampheta-
mine
Canna-
bis
Combined 
Alcohol and 
BZ
Combined 
BZ and 
Cocaine
Green et 
al. 2011 1975 21(419) 10 (201) 2(41) 28(551) n/a n/a n/a n/a
Minett et 
al. 2010 161 31(50) 22(35) 18(29) 44(7) n/a 12(19) n/a n/a
Thiblin et 
al. 2004 192 46(109) 48(114) n/a n/a n/a 17(39) n/a n/a
Wolf et 
al. 2004 98 9(9) 24(23) n/a 21(20) n/a 5(5) n/a 25(24)
Fugelstad 
et al. 
2003
192 29(55) 40(76) n/a 0.5(1) 7(13) 20(39) 17(33) n/a
Perret et 
al. 2000 36 30(11) 50(18) n/a 17(6) n/a n/a n/a n/a
Darke et 
al. 1999 61 33(20) 33(20) n/a n/a n/a n/a 7(4) n/a
Darke et 
al. 1997 39 51(20) 21(8) n/a n/a n/a n/a 10(4) n/a
Hender-
son et al. 
1991
112 38(34) 7(8) 1(2) 16(18) 5(5) n/a n/a n/a
MEAN 32% 28% 3% 5% 2% 2% 11%
n/a = not available
Table 3: Concentration of opioid levels in relation to alcohol and benzodiazepine concentration levels
Study Alcohol concentration levels
 Minett et al. 
(2010)
There was no significant difference in morphine concentrations identified in samples with detectable 
post-mortem concentrations of alcohol equal to or less than the median value of ethanol versus those 
greater than the median (p<0.5)
Darke et al. 
(1999)
Morphine concentrations among cases involving alcohol ranged well below the toxic level for opioid 
naïve individuals.
Fugelstad et al. 
(2003)
A high blood ethanol level was significantly associated with low morphine and 6-MAM levels 
(p<0.01)
Darke et al. 
(1997)
There was a significant negative correlation between blood alcohol and blood morphine concentra-
tions among fatal cases (p<0.001; r2=-0.41)
Study Benzodiazepine concentration levels
Minett et al. 
(2010)
There was no significant difference in morphine concentrations in samples with detectable post-
mortem concentrations of benzodiazepines equal to or less than the median value versus those greater 
than the median (p<0.2)
Fugelstad et al. 
(2003) Higher levels of 6-MAM were associated with the presence of benzodiazepines (p=0.01).
Wolf et al. 
(2004)
The mean methadone concentration among cases with co-intoxication with benzodiazepines was 0.43 
mg/L. The mean methadone concentration among cases with deaths attributed to methadone toxicity 
alone was 0.56 mg/L.
p=probability
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3.3.1.1.2.Benzodiazepines
Nine of the thirteen studies measured the per-
centage of FOO victims that were positive for ben-
zodiazepines [10,11,18,20,22,35,46,53]. The lowest 
percentage of cases found was 7% [22] and the high-
est was 50% [35]. Three studies looked at the acute 
effect of benzodiazepines on fatal opioid concentra-
tions [18,30,53] (Table 3) but the findings were in-
conclusive.
3.3.1.1.3.Other drugs and combination of drugs
Aside from alcohol and benzodiazepines, other 
drugs were found to be contributory acute risk factors 
in FOO in seven studies [18, 20, 22, 30, 35, 46, 53]. 
These other drugs identified in victims were cocaine, 
anti-depressants, amphetamine and cannabis. Only 
two studies examined effects of these on opioid lev-
els [18,30]. Minett et al. [30] found that “morphine 
concentrations were higher in the ‘‘high’’ concentra-
tion group of the antidepressant drug class subset and 
lower in the ‘‘low’’ concentration group (p=0.03)’’. 
Fugelstad et al. [18] found that presence of THC (a 
cannabis metabolite) was associated with signifi-
cantly (p=0.02) lower levels of 6-MAM (a morphine 
metabolite), suggesting that cannabis could increase 
risk of FOO. Combination of opioids with both ben-
zodiazepines and alcohol was considered as the most 
common lethal drug cocktail [10,11,18]. 
3.3.1.2. Route of administration
Only one study [46] examined the role of route 
of administration in overdose fatalities. It found that 
injection and non-injection routes of administra-
tion can be equally lethal. In fatal overdose episodes 
where the route of administration was not injection, 
median morphine concentrations were significantly 
(p=0.002) lower than in those who overdosed by in-
jection.
3.3.1.3. Opioid use after abstinence
Five studies discussed the role of reduced opioid 
tolerance after a period of abstinence in FOO [18, 22, 
34, 44, 46]. All of these studies noted that the major-
ity of overdose victims in their studies had occurred 
being review articles (N=6).
3.3. Acute risk factors
3.3.1. Drug taking behaviours and purity
3.3.1.1. Polydrug use
3.3.1.1.1. Alcool
Nine of thirteen studies measured the percentage 
of overdose victims with a positive blood alcohol lev-
el (Table 2). The lowest percentage of cases in which 
alcohol was detected was 9% [53] and the highest 
was 51% [10]. However, the presence of alcohol in 
fatal overdose victims could be an incidental finding. 
Based on the assumption that the presence of alcohol 
is a risk factor, lower concentrations of opioid levels 
may be fatal due to the summative sedative effects 
of alcohol and opioids taken together. Four studies 
measured concentration of opioid levels in relation to 
alcohol concentration in order to investigate what role 
alcohol may have played in the deaths [10, 11, 18, 30] 
(Table 3).
The role of alcohol may not be as straightfor-
ward as alcohol levels being proportional to an in-
creased risk of death. Fugelstad et al. indicated that 
blood ethanol levels exceeding 0.5 mg/g were needed 
for an increased risk and that this significance on dose 
declined at higher levels of ethanol [18]. Thiblin et al. 
noted that complete long term abstinence from alco-
hol was, in fact, found to be a significant (10% contri-
bution) risk factor [46]. The association was thought 
to be due to the significantly higher proportion of al-
cohol abstainers who report daily use of heroin the 
year before hospital admission than among those who 
report use of alcohol (75% vs 53%, p< 0.001). There-
fore, it appears alcohol concentrations above a certain 
level do increase acute risk of FOO. However, those 
who completely abstain from alcohol may be at an 
increased risk of FOO, not as a result of their lack of 
alcohol use, but as they are more likely to be using 
heroin on a regular basis.
Table 4: Mean morphine concentration in hair samples [44]
Subjects Mean (ng/mg) SD Range (ng/mg)
Fatal Overdose 1·2 2·4 0–12·2
Active Heroin Addicts 6·1 4·3 1·2–17
Abstinent Former Addicts 0·7 0·9 0·1–3·3
SD= Standard Deviation
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in individuals with reduced tolerance as a result of a 
period of abstinence and/or diminished drug use but 
gave no further information. 
A single study focused on abstinence as an acute 
risk factor [44] and found that FOO victims had sig-
nificantly (p<0.001) lower levels of morphine in hair 
samples than active heroin users. However, their mor-
phine levels were not significantly (p=0.98) differ-
ent from former addicts who had been abstaining for 
several months previous to the study. They concluded 
that most of the FOO victims had been abstaining in 
the months previous to their death (Table 4). 
Imprisonment is a common cause of abstinence 
among opioid users and release from prison has been 
associated with an increased risk of overdose [4]. In 
this review, just three studies stated rates of recent 
prison release amongst victims of FOO. No further 
information was given regarding how this related to 
opioid levels.
3.3.1.4. Purity of illicit opioids
Three studies commented on the effects of pu-
rity on risk of FOO [31,34,35]. Green et al. [20] and 
Henderson et al. [22] both found that the peak rate 
of FOO coincided with the peak purity levels of the 
drugs. However it is also worth noting that in both 
cases this coincided with lowest heroin prices and 
highest availability which could have meant increased 
use was responsible for any increase in FOO. Indeed, 
Henderson et al. concluded that ‘the incidence of 
fentanyl-related deaths is probably determined by the 
general availability of the drug, rather than the rela-
tive potency of the analogues’.
Darke et al. [11] measured the range and mean 
heroin purity per fortnight from a total of 322 heroin 
samples analysed over a 2 year period when a total of 
61 FOO episodes occurred in the region. The study 
found that both the range and mean heroin purity 
‘were independent predictors of the number of fa-
talities per fortnight’. Their findings were statistically 
significant (p<0.001) and accounted for 40% of the 
variance, suggesting that purity plays a major role in 
FOO.
3.3.2. Prescribing 
Just one study included in this review covered 
the topic of prescribed opioids for analgesic purposes. 
Using a cohort study design, Bohnert et al. [5] found 
that in comparison with other individuals prescribed 
opioid medication, those who had suffered a FOO 
were significantly more likely to have an acute pain 
condition (p<0.001). Further to this, the article de-
scribed those at greatest risk were prescribed a daily 
scheduled opioid in addition to a required opioid. The 
daily scheduled dose was also found to be an impor-
tant factor in those with acute pain conditions with 
acute risk of FOO increasing significantly (p <0.05) 
with size of dose, particularly those doses above 
50mg daily. The results of this study strongly suggest 
acute pain may be a significant risk factor for FOO 
from hypoxia and/or cardiotoxicity.
4. Discussion
This review has analysed different acute risk 
factors for FOO as a result of hypoxia and/or cardio-
toxicity. The innovative aspect of this review is that it 
is focused on specific acute risk factors and utilised 
better criteria of inclusion/exclusion.
4.1. Main findings
The most robust acute risk factor identified was 
concomitant alcohol use and negative correlations 
with blood opioid levels. This finding is in agreement 
with a number of studies, whose evidence is relevant 
though they did not meet the inclusion criteria for 
this review [56,39,40]. Alcohol is a depressant which 
works via the GABA receptors to produce inhibition 
which affects the respiratory centres [2]. When these 
inhibitory effects are combined with the inhibitory ef-
fects of opioids from their action on µ receptors, it is 
thought to lead to further depression at the respiratory 
centres [51]. Benzodiazepines produce their effects 
through a similar mechanism to alcohol, involving 
GABA receptor binding but binds at an alternative 
site [51]. Although they were a commonly detected 
drug group in victims (mean 28%), this review found 
their role in FOO to be less straightforward than that 
of alcohol alone with very mixed results seen across a 
small number of studies. 
In addition to alcohol, the loss of tolerance to 
opioids due to abstaining from opioids and high pu-
rity of opioids taken before deaths emerged as other 
acute risk factors [44]. Acute pain conditions and 
concomitant daily use of strong prescribed opioids 
(e,g, morphine and oxycodone) were also associated 
with FOO. Other studies have also found higher daily 
doses to be associated with greater risk of overdose 
[12]. 
Limitations
There are a number of limitations to this review. 
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undertake to explain the potential influence/s on FOO 
of premorbid reduction in oxygen saturation during 
sleep [47], blunted hypercapnic ventilatory response 
(HCVR) and hypoxic ventilatory responses (HVR) 
in opioid dependent individuals [45]. This is com-
pounded by the known cardiotoxic effects of opioids 
[6] and associated ischaemic changes in the opioid 
using population [1]. Future studies should investi-
gate these potential biological and mechanistic fac-
tors that might lead to susceptible individuals having 
a fatal opioid overdose.
5. Conclusions 
The limited number of studies identified in this 
review highlights the need to investigate further with 
detailed biological markers the conditions why some 
individuals die of an opioid related hypoxic or car-
diotoxic event, but also the premorbid conditions that 
might make some individuals more susceptible to a 
fatal hypoxic/cardiotoxic outcome. This will support 
further the notion that fatal overdoses are a combina-
tion of acute and premorbid risk factors that might 
have a biological and mechanistic basis.
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